You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

24,25(OH)2D3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitamin D Deficiency Trial in Jakarta Pusat (Cholecalciferol)

Active, not recruiting
  • Vitamin D Deficiency
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo National Center General Hospital
Sep 22, 2023

Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective Trial in Cuernavaca (vitamin D-enhanced egg, Control)

Completed
  • Vitamin D Deficiency
  • 25-Hydroxyvitamin D3 Deficiency, Selective
  • vitamin D-enhanced egg
  • Control
  • Cuernavaca, Morelos, Mexico
    Instituto Nacional de Salud Pública
Oct 19, 2023

Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid

Recruiting
  • Nutrition, Healthy
  • DHA/EPA bioenhanced chicken
  • 25(OH)D bioenhanced chicken
  • Ithaca, New York
    Human Metabolic Research Unit
Jun 3, 2022

Chronic Kidney Disease Trial in Seattle (D6-25-hydroxyvitamin D3)

Completed
Has Results
  • Chronic Kidney Disease
  • D6-25-hydroxyvitamin D3
  • Seattle, Washington
    University of Washington
May 14, 2022

Vitamin D Deficiency Trial in Warszawa (Cholecalciferol 120 000 IU)

Completed
  • Vitamin D Deficiency
  • Cholecalciferol 120 000 IU
  • Warszawa, Poland
    Department of Endocrinology, Centre of Postgraduate Medical Educ
Oct 19, 2022

Mental Health Issue Trial in Haveli (25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3., Placebo)

Not yet recruiting
  • Mental Health Issue
  • 25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3.
  • Placebo
  • Haveli, Azad Jammu And Kashmir, Pakistan
    District Headquarter Hospital Haveli
Oct 24, 2023

Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
  • 25(OH)D3
  • vitamin D3
  • (no location specified)
Apr 16, 2022

Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)

Completed
  • Pituitary ACTH Hypersecretion
  • +3 more
  • Cholecalciferol 15000 UNT/ML Oral Solution
  • Moscow, Russian Federation
    Endocrinology Research Centre, Moscow
Aug 10, 2022

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Chronic Kidney Disease Trial in Seattle (D6-25-hydroxyvitamin D3)

Completed
Has Results
  • Chronic Kidney Disease
  • D6-25-hydroxyvitamin D3
  • Seattle, Washington
    University of Washington
Aug 31, 2021

COVID-19, Vitamin D Deficiency Trial in Riga (Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion)

Completed
  • COVID-19
  • Vitamin D Deficiency
  • Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion
  • Riga, Latvia
    Pauls Stradins Clinical Univeristy Hospital
Aug 15, 2022

Cardiovascular Disease, Vitamin D Deficiency Trial in Murray (Vitamin D3, Placebo)

Completed
  • Cardiovascular Disease
  • Vitamin D Deficiency
  • Vitamin D3
  • Placebo
  • Murray, Utah
    Intermountain Heart Institute
Apr 1, 2021

Vitamin D Deficiency, Scleroderma, Systemic Trial in Mexico City (Vitamin D3, Dietary recommendations)

Completed
  • Vitamin D Deficiency
  • Scleroderma, Systemic
  • Vitamin D3
  • Dietary recommendations
  • Mexico City, Mexico
    Instituto Méxicano del Seguro Social
Apr 19, 2021

Macrophage Migration Inhibitory Factor and 25(OH) Vitamin D3

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Jan 24, 2021

    Vitamin D Deficiency Trial in Los Angeles (Vitamin D, 25(OH)D3)

    Completed
    • Vitamin D Deficiency
    • Los Angeles, California
    • +1 more
    Apr 26, 2021

    Lung Cancer Trial (TILT-123, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • TILT-123
    • Pembrolizumab
    • (no location specified)
    Nov 5, 2023

    Vitamin D Deficiency Trial in Le Sueur (dietary supplement, diagnostic test, other)

    Completed
    • Vitamin D Deficiency
    • Softgel Vitamin D3
    • +3 more
    • Le Sueur, Minnesota
      Inspired Life Medical Office
    Aug 23, 2021

    Chronic Heart Failure, Vitamin D Adverse Reaction Trial in Budapest (Vigantol oil and MCT oil)

    Terminated
    • Chronic Heart Failure
    • Vitamin D Adverse Reaction
    • Vigantol oil and MCT oil
    • Budapest, Hungary
    • +1 more
    Apr 8, 2021

    SARS-CoV 2 Trial (Zinc gluconate, 25-OH cholecalciferol)

    Withdrawn
    • SARS-CoV 2
    • Zinc gluconate
    • 25-OH cholecalciferol
    • (no location specified)
    Mar 8, 2021

    Diabetes, Type 2, Kidney Diseases Trial in Amman (Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol)

    Completed
    • Diabetes Mellitus, Type 2
    • Kidney Diseases
    • Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.
    • Amman, Jordan
      Mahmoud S Abu-Samak
    Feb 23, 2022

    Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25

    Unknown status
    • Infertility, Female
    • Plasma level of vitamin D
    • Tübingen, Germany
      University Women's Hospital
    Feb 10, 2020

    Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)

    Recruiting
    • Atopic Dermatitis
    • Lebrikizumab
    • Darmstadt, Hessen, Germany
    • +31 more
    Jun 21, 2023

    Diaphragmatic Paralysis, Brachial Plexus Block Trial in Zaragoza (Interscalene brachial plexus block, Levobupivacaine

    Completed
    • Diaphragmatic Paralysis
    • Brachial Plexus Block
    • Interscalene brachial plexus block
    • Levobupivacaine Hydrochloride 2.5 MG/ML
    • Zaragoza, Spain
      Hospital Universitario Miguel Servet
    Aug 9, 2022

    Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

    Recruiting
    • Platinum-refractory Ovarian Carcinoma
    • Platinum-resistant Ovarian Cancer
    • TILT-123
    • Pembrolizumab
    • Rochester, Minnesota
    • +1 more
    Aug 12, 2022

    Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

    Recruiting
    • Recurrent Hodgkin Lymphoma
    • Refractory Hodgkin Lymphoma
    • Basiliximab
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Jun 16, 2022